Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOPOCIS neoadjuvant weekly topotecan and cisplatin in locally advanced squamous cervical cancer
2008-005176-28Phase 2Completed
- Sponsor
- Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of topotecan and cisplatin in cervical squamous cell carcinoma (CSCC), sponsored by Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano. Primary endpoint: Clinical tumor response. Started Sep 2009; status: completed.
02
Drugs
topotecancisplatin
03
Conditions
cervical squamous cell carcinoma (CSCC)
Beyond the preview
Go deeper on 2008-005176-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005176-28.